课题基金 / 基金详情

Task V12: Clinical Sample Testing for SARS-CoV-2 Vaccine Candidates

Task V12: Clinical Sample Testing for SARS-CoV-2 Vaccine Candidates
任务 V12：SARS-CoV-2 候选疫苗的临床样本测试
批准号：
10267386
负责人：
THOMAS RUDGE
金额：
$639.85万
依托单位：
BATTELLE CENTERS/PUB HLTH RES & EVALUATN
依托单位国家：
美国
项目类别：
财政年份：
2020
资助国家：
美国
项目状态：
已结题
起止时间：
2020-09-18 至 2022-09-17
来源：
https://reporter.nih.gov/project-details/10267386
关键词：
2019-nCoVBiologicalBioterrorismCOVID-19ClinicalCommunicable DiseasesContractsDevelopmentEmerging Communicable DiseasesFeasibility StudiesPhaseSamplingServicesTestingToxicity TestsVaccinesassay developmentefficacy testingevaluation/testingimmunogenicitynovel coronavirusnovel vaccinesproduct developmentsafety testingtesting servicesvaccine candidatevaccine development

项目摘要

项目成果

THOMAS RUDGE的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The Evaluation and Testing Services (ETS) for Vaccines and Other Biologics for Infectious Diseases contract provides a variety of product development services from early feasibility studies through manufacture of Phase I/II material, including assay development; immunogenicity and efficacy testing; clinical and nonclinical sample testing; and safety and toxicity testing. These services will facilitate the development and introduction of new vaccines and biologics against potential agents of bioterrorism and emerging and re-emerging infectious diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Task V18: STUDY TO EVALUATE THE EFFICACY OF TOXIN IN ANIMAL MODEL
TASK V17: DEVELOPMENT OF ASSAYS AND REAGENTS FOR MONKEYPOX VACCINES
TASK V13: DEEP ANTIBODY PROFILING FOR INFECTION AND VACCINATION
Task V12: CLINICAL SAMPLE TESTING FOR ZIKA VIRUS VACCINES
海外基金